Phase 2RecruitingAge-related condition
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases (FAPIPET)
- Sponsor
- Erasme University Hospital (Academic or other)
- Enrolment
- 70 planned
- Conditions
- Pulmonary Fibrosis; Lung Fibrosis; Idiopathic Pulmonary Fibrosis; FAP
- Interventions
- FAPI PET/CT
- Ages
- adults, older adults
- Registry
- NCT06189820
Full record on ClinicalTrials.gov
From the registry
To evaluate the effect of an anti-fibrotic treatment initiation on the fibrotic activity as assessed by FAPI PET/CT.
Primary outcomes
- FAPI uptake on PET/CT
History
Primary completion expected
Last registry update
Registered
Started